This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Immunosuppressive Therapy

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Immunosuppressive Therapy Means

Immunosuppressive therapy refers to treatments that lower the activity of the body’s immune system. The immune system normally helps protect the body by fighting infections and abnormal cells, including cancer cells. When immunosuppressive therapy is used, it reduces this protective activity. This can be helpful in certain medical situations, such as preventing the body from rejecting a transplanted organ or bone marrow, or treating autoimmune diseases where the immune system mistakenly attacks the body’s own tissues.

Why Immunosuppressive Therapy Can Matter in Cancer Care

Because immunosuppressive therapy lowers the immune system’s ability to fight abnormal cells, it may increase the risk of developing cancer. This is an important consideration for patients receiving these treatments. In cancer care, immunosuppressive therapy might be part of managing complications or side effects, such as preventing rejection after a stem cell transplant or controlling autoimmune problems triggered by cancer or its treatment. Some immunosuppressive agents are antibodies that act quickly and powerfully, like anti-CD20 monoclonal antibodies. Understanding the role of immunosuppressive therapy helps patients and caregivers recognize why it might be included in a treatment plan and what risks it may carry.

What Patients Might See or Hear About Immunosuppressive Therapy

Patients may come across the term immunosuppressive therapy in medical reports, treatment plans, or discussions with their healthcare team. They might also hear about specific drugs used alongside immunosuppressive therapy, such as Cablivi (caplacizumab), which is used with plasma exchange and immunosuppressive medicines to treat a rare blood disorder called acquired thrombotic thrombocytopenic purpura (aTTP). This condition involves small blood clots forming in vessels throughout the body and can be linked to cancer or cancer treatments. Hearing these terms can be confusing, so it’s important to ask the care team how immunosuppressive therapy fits into the overall treatment and what to expect.

Common Sources of Confusion and Practical Questions

Because immunosuppressive therapy covers many different drugs and uses, patients and caregivers might find the term confusing or worry about its effects. It’s helpful to remember that the word alone is not a diagnosis or a treatment recommendation. Patients can ask their care team questions like: Why is immunosuppressive therapy recommended for me? How does it work? What are the possible side effects? How does it affect my cancer risk? How will we monitor its effects? Clear communication helps patients feel more confident and involved in their care decisions.

How to Understand Immunosuppressive Therapy in Context

When you see the term immunosuppressive therapy, it’s important to consider the full medical context. This therapy might be part of a plan to prevent transplant rejection, treat autoimmune conditions, or manage blood disorders like aTTP. It is not a cancer treatment itself but may be used alongside cancer therapies or to handle side effects. Always ask your healthcare team to explain how immunosuppressive therapy applies to your specific situation rather than assuming its meaning from the word alone.

Safety and Next Steps

This information is meant to help you understand what immunosuppressive therapy means and why it might be part of your care. It does not replace medical advice or decisions tailored to your health. If you see this term in your medical records or hear it during visits, the best next step is to ask your care team what it means for you personally. They can explain how it fits into your treatment, what benefits and risks it carries, and what to watch for during therapy.

Sources

Public source information used for this glossary entry includes: